HIF1A and endometrial carcinoma: To explore the value of quantitative imaging parameters by enhanced T2* weighted angiography (ESWAN) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for evaluating the expression of Hypoxia-inducible factor-1α (HIF-1α) in endometrial carcinoma (EC).